All News Virbac

Equities

Market Closed - Euronext Paris Other stock markets 16:35:24 30/04/2024 BST			5-day change	1st Jan Change
347 ^EUR	-0.57%		-2.80%	-3.48%

04-17	VIRBAC : A healthy start to 2024; outlook re-iterated
04-17	Virbac: sales up by almost 10% in Q1	CF

Virbac : Public release of Virbac Annual Report at 31 December 2023 (ESEF format)	04-24	GL
VIRBAC : A healthy start to 2024; outlook re-iterated	04-17
Virbac: sales up by almost 10% in Q1	04-17	CF
VIRBAC: Building on the momentum of the second half of 2023, strong first-quarter revenue growth of +10.8% at constant exchange rates	04-16	GL
Virbac SA Announces Revenue Results for the First Quarter of 2024	04-16	CI
Virbac : Déclaration d'actions et de droits de vote 03/2024	04-09	PU
Virbac: 'strategic' acquisition of Sasaeah in Japan	04-02	CF
Virbac acquired Sasaeah, a leading animal health player in Japan	04-02	GL
Virbac SA acquired Sasaea Holdings Co., Ltd. from ORIX Corporation.	03-31	CI
VIRBAC : Oddo BHF maintains its recommendation on the stock	03-21	CF
CAC40: damage limited despite Kering's fall	03-20	CF
Transcript : Virbac SA, 2023 Earnings Call, Mar 20, 2024	03-20
Virbac: net income unchanged overall in 2023	03-20	CF
Virbac: Public Release of the Year-End Consolidated Accounts at 31 December 2023	03-19	GL
Virbac : Consolidated accounts_2023	03-19	PU
VIRBAC: 2023 ANNUAL RESULTS	03-19	GL
VIRBAC: 2023 ANNUAL RESULTS	03-19	AQ
Virbac Sa Provides Earnings Guidance for the Year 2024	03-19	CI
Virbac Sa Proposes Dividend for the Year 2023	03-19	CI
Virbac SA Reports Earnings Results for the Full Year Ended December 31, 2023	03-18	CI

No results for this search

VIRBAC : A healthy start to 2024; outlook re-iterated

April 17, 2024 at 05:39 pm